EllenRx® Prior Authorization Card

Solriamfetol (Sunosi)

FDA-approved uses
Narcolepsy, Obstructive sleep apnea
How it's given
By mouth
Typical first approval
12 months
Sources checked
2026-11-10

What payers commonly require

  • Sleep study confirming the diagnosisInsurers want sleep test results that confirm narcolepsy or obstructive sleep apnea (OSA).Source: Aetna, UnitedHealthcare
  • Tried modafinil or armodafinil first and, at some plans, a stimulantInsurers usually want proof that modafinil or armodafinil did not work, caused problems, or is not safe for you.Source: Aetna, UnitedHealthcare
  • For OSA: used CPAP or BiPAP 1+ monthFor sleep apnea, Sunosi does not treat the blocked airway, so insurers and the label want CPAP or BiPAP used for at least a month first.Source: Aetna, UnitedHealthcare, FDA label
  • For OSA: still using CPAP or BiPAPFor sleep apnea, insurers want you to keep using your breathing machine while taking Sunosi.Source: Aetna, UnitedHealthcare, FDA label
  • To renew: less sleepiness than beforeTo keep coverage, insurers want to see that your daytime sleepiness got better on Sunosi.Source: Aetna, UnitedHealthcare

Each plan has its own policy. Check the patient's plan before submitting.

Letter of medical necessity

Address each item above in the letter and attach the chart notes that show it: the diagnosis, prior treatments with dates and results, and any required test results.

Draft a letter with Ellen

Patients: see the Solriamfetol patient page.

Sources: FDA label (DailyMed), Aetna (June 15, 2026), UnitedHealthcare (Effective Date 11/16/2025).

Not medical advice. For educational use by clinic staff. Ellen does not diagnose conditions or recommend treatments. Payer policies change often; confirm with the patient's plan.